Cargando…

Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy

OBJECTIVE: Cervical cancer is the second most common cancer in Thailand. For cervical cancer, there is no cancer specific quality of life questionnaire. This study aims to develop and validate Thai FACT-CX. METHODS: The cross-sectional study included all women aged ≥18 years with stage IB2-IIIB who...

Descripción completa

Detalles Bibliográficos
Autores principales: Peerawong, Thanarpan, Suphasynth, Yuthasak, Kongkamol, Chanon, Rordlamool, Paytai, Bridhikitti, Jidapa, Sangtawan, Duangjai, Jiratrachu, Rungarun, Atjimakul, Thiti, Chicharoen, Saibua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573411/
https://www.ncbi.nlm.nih.gov/pubmed/32711412
http://dx.doi.org/10.31557/APJCP.2020.21.7.1891
_version_ 1783597436821831680
author Peerawong, Thanarpan
Suphasynth, Yuthasak
Kongkamol, Chanon
Rordlamool, Paytai
Bridhikitti, Jidapa
Sangtawan, Duangjai
Jiratrachu, Rungarun
Atjimakul, Thiti
Chicharoen, Saibua
author_facet Peerawong, Thanarpan
Suphasynth, Yuthasak
Kongkamol, Chanon
Rordlamool, Paytai
Bridhikitti, Jidapa
Sangtawan, Duangjai
Jiratrachu, Rungarun
Atjimakul, Thiti
Chicharoen, Saibua
author_sort Peerawong, Thanarpan
collection PubMed
description OBJECTIVE: Cervical cancer is the second most common cancer in Thailand. For cervical cancer, there is no cancer specific quality of life questionnaire. This study aims to develop and validate Thai FACT-CX. METHODS: The cross-sectional study included all women aged ≥18 years with stage IB2-IIIB who planned to undergo chemoradiotherapy. Those who did not understand Thai language, had other cancers (except for skin cancer), were diagnosed with impaired cognition and/or overt psychosis, and major depression were excluded. The FACT-CX comprises 42 items with 5 domains and a score range of 0-168. The WHOQOL-BREF comprises 26 items with 4 domains and a score range of 26-130. The participants were interviewed about demographic and clinical data. Both questionnaires were self-completed. Factor analysis was used to compare our data with the previous structure. The reliability used Cronbach’s alpha. Spearman’s correlation determined relationship between the domains of the modified FACT-CX and WHOQOL-BREF. Both questionnaires were compared with socioeconomic and clinical variables using the Ranksum test and Kruskal-Wallis test. P-value > 0.05 considered significant. RESULTS: The 245 participants included. Expletory factor analysis revealed an accumulative variance of 0.42 with 4 factors. The internal consistency was 0.84, 0.81, 0.78, 0.77 and 0.90 for perception of self, suffering symptoms, family support, life resilience and total questions. There was correlation between the domains of the modified FACT-CX and WHOQOL-BREF. Both the modified FACT-CX and WHOQOL-BREF could identify differences between the groups of patients. CONCLUSION: Finally, the Thai modified FACT-CX was found to be reliable and valid for measuring quality of life among untreated cervical cancer patients.
format Online
Article
Text
id pubmed-7573411
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-75734112020-10-30 Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy Peerawong, Thanarpan Suphasynth, Yuthasak Kongkamol, Chanon Rordlamool, Paytai Bridhikitti, Jidapa Sangtawan, Duangjai Jiratrachu, Rungarun Atjimakul, Thiti Chicharoen, Saibua Asian Pac J Cancer Prev Research Article OBJECTIVE: Cervical cancer is the second most common cancer in Thailand. For cervical cancer, there is no cancer specific quality of life questionnaire. This study aims to develop and validate Thai FACT-CX. METHODS: The cross-sectional study included all women aged ≥18 years with stage IB2-IIIB who planned to undergo chemoradiotherapy. Those who did not understand Thai language, had other cancers (except for skin cancer), were diagnosed with impaired cognition and/or overt psychosis, and major depression were excluded. The FACT-CX comprises 42 items with 5 domains and a score range of 0-168. The WHOQOL-BREF comprises 26 items with 4 domains and a score range of 26-130. The participants were interviewed about demographic and clinical data. Both questionnaires were self-completed. Factor analysis was used to compare our data with the previous structure. The reliability used Cronbach’s alpha. Spearman’s correlation determined relationship between the domains of the modified FACT-CX and WHOQOL-BREF. Both questionnaires were compared with socioeconomic and clinical variables using the Ranksum test and Kruskal-Wallis test. P-value > 0.05 considered significant. RESULTS: The 245 participants included. Expletory factor analysis revealed an accumulative variance of 0.42 with 4 factors. The internal consistency was 0.84, 0.81, 0.78, 0.77 and 0.90 for perception of self, suffering symptoms, family support, life resilience and total questions. There was correlation between the domains of the modified FACT-CX and WHOQOL-BREF. Both the modified FACT-CX and WHOQOL-BREF could identify differences between the groups of patients. CONCLUSION: Finally, the Thai modified FACT-CX was found to be reliable and valid for measuring quality of life among untreated cervical cancer patients. West Asia Organization for Cancer Prevention 2020-07 /pmc/articles/PMC7573411/ /pubmed/32711412 http://dx.doi.org/10.31557/APJCP.2020.21.7.1891 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Peerawong, Thanarpan
Suphasynth, Yuthasak
Kongkamol, Chanon
Rordlamool, Paytai
Bridhikitti, Jidapa
Sangtawan, Duangjai
Jiratrachu, Rungarun
Atjimakul, Thiti
Chicharoen, Saibua
Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy
title Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy
title_full Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy
title_fullStr Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy
title_full_unstemmed Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy
title_short Validation of the Functional Assessment of Cancer Therapy with Cervical Cancer Subscale (FACT-CX) for Quality of Life in Thai Patients Prior to Chemoradiotherapy
title_sort validation of the functional assessment of cancer therapy with cervical cancer subscale (fact-cx) for quality of life in thai patients prior to chemoradiotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573411/
https://www.ncbi.nlm.nih.gov/pubmed/32711412
http://dx.doi.org/10.31557/APJCP.2020.21.7.1891
work_keys_str_mv AT peerawongthanarpan validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT suphasynthyuthasak validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT kongkamolchanon validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT rordlamoolpaytai validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT bridhikittijidapa validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT sangtawanduangjai validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT jiratrachurungarun validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT atjimakulthiti validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy
AT chicharoensaibua validationofthefunctionalassessmentofcancertherapywithcervicalcancersubscalefactcxforqualityoflifeinthaipatientspriortochemoradiotherapy